Systemic lupus erythematosus with membranous glomerulonephritis and transverse myelitis associated with anabolic steroid use

Arthritis and Rheumatism

Volumn 40, Issue 10, 1997, Pages 1899-1902

  Radis, Charles D ^a   Callis, Kristina P ^a  

^a Rheumatology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HEPARIN; HYDROXYCHLOROQUINE; ISONIAZID; METHYLPREDNISOLONE; NANDROLONE; PREDNISONE; STEROID;

ADULT; ARTHRALGIA; ARTICLE; ATHLETE; BODY BUILDING; CASE REPORT; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG SELF ADMINISTRATION; EDEMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MYELITIS; ORAL DRUG ADMINISTRATION; PARALYSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANABOLIC AGENTS; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MYELITIS, TRANSVERSE; NANDROLONE; PITUITARY NEOPLASMS; PROLACTINOMA; WEIGHT LIFTING;

EID: 0030827982     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401027     Document Type: Article

References (15)

1. Inman RD: Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthritis Rheum 21:849-852, 1978
2. Lahita RG, Bradlow HL, Kunkel HG, Fishman J: Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 22:1195-1198, 1979
3. Stern R, Fishman J, Brusman H, Kunkel HG: Systemic lupus erythematosus associated with Klinefelter's syndrome. Arthritis Rheum 20:18-22, 1977
4. Folomeev M, Prokaeva T, Nassonova V, Nossonov E, Masenko V, Ovtraht N: Prolactin levels in men with SLE and RA (letter). J Rheumatol 17:1569-1570, 1990
5. Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR: Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 303:222-226, 1992
6. Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, Gonzalez-Barcena D, Fraga A: Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 14:268-272, 1987
7. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE: Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 21:843-850, 1994
8. Pauzner R, Urowitz MB, Gladman DD, Gough JM: Prolactin in systemic lupus erythematosus. J Rheumatol 21:2064-2067, 1994
9. Tan EM, Cohcn AS, Fries JF, Masi AT, McShanc DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
10. Calabrese LH, Kleiner SM, Barna BP, Skibinski CL, Kirkendall DT, Lahita RG, Lombardo JA: The effects of anabolic steroids and strength training on the human immune response. Med Sci Sports Exerc 21:386-392, 1989
11. Hazelton RA, McCruden AB, Sturrock RD, Stimson WH: Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann Rheum Dis 42:155-157, 1983
12. Verheul HA, Stimson WH, den Hollander FC, Schuurs AH: The effect of nandrolone, testosterone and their decanoate esters on murine lupus. Clin Exp Immunol 94:11-17, 1981
13. Lahita RG, Cheng CY, Monder C, Bardin CW: Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J Rheumatol 19:547-555, 1992
14. Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magun BE: Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 134:3027-3031, 1985
15. McMurray RW, Weidensaul D, Allen SH, Walker SE: Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 22:2084-2091, 1995